CAR T-cells: an advancement in treating MM?
Results of Phase Ib/II study of ricolinostat in multiple myeloma
Perspectives on future paths to cure multiple myeloma
SWOG S0777 trial: lenalidomide, dexamethasone and bortezomib for the treatment of MM
What does a physician need to consider when treating relapsed or refractory myeloma?